Preclinical Animal Models: Selection & Rationale

About
Privacy
Disclaimer

Graph Chatbot

Related lectures (32)

Page 3 of 4

Small Molecule Drugs: Cardiovascular Diseases

Explores the molecular basis and treatment of cardiovascular diseases, focusing on atherosclerosis, hypertension, and drug therapies.

Enzyme Drug Targets

Explores enzyme drug targets, tyrosine kinase inhibitors, vascular tone control, and viral life cycle interventions.

Space 4 Healthcare: Microgravity Applications in Biotechnology

Delves into microgravity applications in biotechnology, addressing challenges on Earth and the potential solutions offered by space production.

Introduction: small molecule drugs for cancer

Introduces small molecule drugs for cancer treatment, covering drug discovery, mechanisms of action, and historical development of anti-cancer agents.

RNA-based Approaches to Disease Treatment

Explores RNA-based disease treatment, synthetic biology impact on therapeutics, and programmable RNA-targeting tools.

Selective Drug Targeting Mechanisms

Explores selective drug targeting mechanisms, resistance development, tuberculosis incidence, BCR-ABL mutations, tyrosine kinase inhibitors, drug toxicity, interactions, and toxicology studies.

Proteome Mapping & Electrophile Responsivity

Explores proteome mapping, electrophile responsivity, precision medicine, and spatial omics technologies in drug target identification.

Tissue Engineering for Cancer Research

Explores the complexity of cancer, challenges in research translation, and the applications of tissue engineering for cancer models and drug screening.

The ClpXP Proteolytic Complex: Basic Principles to Drug Discovery

Explores the ClpXP proteolytic complex, its drug targeting potential, and antimicrobial applications through compound screening.

Drug-Induced Liver Injury (DILI): Mechanisms and Mitigation

Delves into Drug-Induced Liver Injury (DILI) mechanisms, metabolism, and mitigation strategies in drug development.